SCHEDULE: Cormorant Asset Management Divests Rallybio Stake
Schedule 13G Amendment
Cormorant Asset Management, LP and Bihua Chen have reported a 0.0% beneficial ownership of Rallybio Corp. common stock, indicating a complete divestment.
Summary
- Cormorant Asset Management, LP and Bihua Chen have filed an amendment to their Schedule 13G, reporting zero shares beneficially owned in Rallybio Corp.
- This filing indicates a complete divestment of their holdings in Rallybio Corp. common stock.
- The previous filing referenced a total of 5,298,137 shares of Common Stock outstanding as of May 8, 2026.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a negative sentiment due to the complete divestment of shares, indicating a lack of confidence or a strategic shift away from the company.
Negatives
- Cormorant Asset Management, LP and Bihua Chen have zero shares beneficially owned, signifying a complete exit from their investment in Rallybio Corp.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that a complete divestment by a significant holder like Cormorant Asset Management, an investment advisor, often signals a lack of conviction in the company's future prospects or a reallocation of capital to other opportunities.
Stakeholder Impact
- Shareholders may view this divestment as a negative signal, potentially impacting stock price due to reduced institutional support.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Quarterly period ended for Form 10-Q reference. |
| 05/08/2026 | Date as of which shares of Common Stock were outstanding. |
| 05/13/2026 | Date of filing of Rallybio Corp. Quarterly Report on Form 10-Q. |
| 05/15/2026 | Date of previous Schedule 13G filing by Reporting Persons. |
| 06/30/2026 | Date of Event Which Requires Filing of this Statement (Amendment No. 1). |
| 08/14/2026 | Date of signature for Cormorant Asset Management, LP and Bihua Chen. |
Recommendation
sellThe complete divestment by Cormorant Asset Management, an investment advisor, suggests a loss of confidence in Rallybio Corp.'s future prospects, warranting a sell recommendation.
Keywords
Rallybio Corp, Cormorant Asset Management, Schedule 13G, Divestment, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.